Hsu RK - Search Results

1

Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort.

Sension MG, Brunet L, Hsu RK, Fusco JS, Cochran Q, Uranaka C, Sridhar G, Vannappagari V, Van Wyk J, McCurdy L, Wohlfeiler MB, Fusco GP. Sension MG, et al. Among authors: hsu rk. Infect Dis Ther. 2023 Dec;12(12):2807-2817. doi: 10.1007/s40121-023-00890-2. Epub 2023 Nov 15. Infect Dis Ther. 2023. PMID: 37966701 Free PMC article.

2

Maraviroc for previously treated patients with R5 HIV-1 infection.

Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW, van der Ryst E, Mayer H; MOTIVATE Study Teams. Gulick RM, et al. N Engl J Med. 2008 Oct 2;359(14):1429-41. doi: 10.1056/NEJMoa0803152. N Engl J Med. 2008. PMID: 18832244 Free PMC article. Clinical Trial.

3

Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study.

Molina JM, Lamarca A, Andrade-Villanueva J, Clotet B, Clumeck N, Liu YP, Zhong L, Margot N, Cheng AK, Chuck SL; Study 145 Team. Molina JM, et al. Lancet Infect Dis. 2012 Jan;12(1):27-35. doi: 10.1016/S1473-3099(11)70249-3. Epub 2011 Oct 18. Lancet Infect Dis. 2012. PMID: 22015077 Clinical Trial.

4

Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice.

Lackey P, Mills A, Carpio F, Hsu R, DeJesus E, Pierone G, Henegar C, Fusco J, Fusco G, Wohlfeiler M. Lackey P, et al. Clin Drug Investig. 2017 Jan;37(1):51-60. doi: 10.1007/s40261-016-0456-1. Clin Drug Investig. 2017. PMID: 27587070 Free PMC article.

5

Psychiatric Symptoms in Patients Receiving Dolutegravir.

Fettiplace A, Stainsby C, Winston A, Givens N, Puccini S, Vannappagari V, Hsu R, Fusco J, Quercia R, Aboud M, Curtis L. Fettiplace A, et al. J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):423-431. doi: 10.1097/QAI.0000000000001269. J Acquir Immune Defic Syndr. 2017. PMID: 27984559 Free PMC article.

6

Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA-B*5701 Screening as a Risk-Mitigation Measure.

Stainsby CM, Perger TM, Vannappagari V, Mounzer KC, Hsu RK, Henegar CE, Oyee J, Urbaityte R, Lane CE, Carter LM, Pakes GE, Shaefer MS. Stainsby CM, et al. Among authors: hsu rk. Pharmacotherapy. 2019 Jan;39(1):40-54. doi: 10.1002/phar.2196. Epub 2018 Dec 11. Pharmacotherapy. 2019. PMID: 30414209 Free PMC article.

7

Psychiatric outcomes observed in patients living with HIV using six common core antiretrovirals in the Observational Pharmaco-Epidemiology Research and Analysis database.

Hsu R, Fusco J, Henegar C, Mounzer K, Wohlfeiler M, Vannappagari V, Aboud M, Curtis L, Fusco G. Hsu R, et al. Ther Adv Drug Saf. 2018 Oct 29;9(12):675-686. doi: 10.1177/2042098618798350. eCollection 2018 Dec. Ther Adv Drug Saf. 2018. PMID: 30546862 Free PMC article.

8

HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA^® observational database: a cohort study.

Mounzer K, Hsu R, Fusco JS, Brunet L, Henegar CE, Vannappagari V, Stainsby CM, Shaefer MS, Ragone L, Fusco GP. Mounzer K, et al. AIDS Res Ther. 2019 Jan 16;16(1):1. doi: 10.1186/s12981-019-0217-3. AIDS Res Ther. 2019. PMID: 30651100 Free PMC article.

9

Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA.

Mills AM, Schulman KL, Fusco JS, Brunet L, Hsu R, Beyer A, Prajapati G, Mounzer K, Fusco GP. Mills AM, et al. HIV Med. 2020 May;21(5):299-308. doi: 10.1111/hiv.12826. Epub 2020 Jan 27. HIV Med. 2020. PMID: 31985887 Free PMC article.

10

Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs.

Hsu R, Brunet L, Fusco JS, Mounzer K, Vannappagari V, Henegar CE, Van Wyk J, Curtis L, Lo J, Fusco GP. Hsu R, et al. AIDS. 2021 Jan 1;35(1):81-90. doi: 10.1097/QAD.0000000000002718. AIDS. 2021. PMID: 33048874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters